Renoprotective effects of vitamin D analogs (Q44608421)

4 December 2017

Renoprotective effects of vitamin D analogs (English)

1 reference

4 December 2017

0 references

0 references

Yan Chun Li

1

1 reference

PubMed ID

19471320

4 December 2017

language of work or name

English

0 references

publication date

27 May 2009

1 reference

4 December 2017

1 reference

4 December 2017

78

1 reference

4 December 2017

134-139

1 reference

4 December 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2009.175

4 December 2017

0 references

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

The nuclear vitamin D receptor: biological and molecular regulatory properties revealed.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Vitamin D and human health: lessons from vitamin D receptor null mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Noncalcemic Actions of Vitamin D Receptor Ligands

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Renin-angiotensin-aldosterone system and progression of renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

The two NF-kappaB activation pathways and their role in innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Transcription factor-kappa B (NF-kappa B) and renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Vitamin D levels and patient outcome in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Vitamin D receptor activation and survival in chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Association of oral calcitriol with improved survival in nondialyzed CKD.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Mortality risk among hemodialysis patients receiving different vitamin D analogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

1,25-Dihydroxyvitamin D3decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Suppression of renin-angiotensin gene expression in the kidney by paricalcitol

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Renoprotective role of the vitamin D receptor in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

The intrarenal renin-angiotensin system and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Aliskiren combined with losartan in type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Direct renin inhibition with aliskiren in hypertension and target organ damage

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Antiproteinuric effect of oral paricalcitol in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-{kappa}B pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Analogs of 1alpha,25-dihydroxyvitamin D(3) as novel inhibitors of renin biosynthesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Targeted vitamin D receptor expression in juxtaglomerular cells suppresses renin expression independent of parathyroid hormone and calcium

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.175

7 January 2021

Identifiers

DOI

10.1038/KI.2009.175

1 reference

4 December 2017

1 reference

PubMed ID

19471320